The Evidence Based Rheumatology Podcast
Health & Fitness:Medicine
Important trial on the podcast this week! I take a deep dive into the recently published SAPHYR study, which evaluated the use of the IL6 inhibitor sarilumab for patients with PMR. A few aggravating quibbles but overall a very useful trial and an important step forward for patients with PMR.
Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2303452
E71: MTX Discontinuation Post... Influenza Vaccination
E70: Rheum4Debate - HCQ Levels Should Be Monitored in Patients with SLE
E69: Publication Trends in SRMAs and RCTs
E68: SELECT-CHOICE Upadacitinib vs Abatacept in RA
E67: Belimumab in Lupus Nephritis (BLISS-LN)
E66: MRI to Diagnose PMR
E65: Anifrolumab in SLE - A Reply
E63: Housekeeping #3
E57: PEXIVAS Trial - PLEX and Reduced Steroid in ANCA Vasculitis
E56: Continue or Withdraw Prednisone in SLE (CORTICOLUP)
E55: Anifrolumab for SLE (TULIP 1&2)
E54: Rheum4Debate - Triple Tx is 1st Line in RA w/No Response to MTX
E53: Another Look at Nintedanib for SSc-ILD
E52: HOPE RCT - Prednisone for OA of the Hand
E51: Rheum4Debate - "Start TCZ Upfront in GCA"
E50: Housekeeping 2
E49: IL17i vs. TNFi for Psoriatic Arthritis (SPIRIT-H2H)
E48: ADACTA - Tocilizumab or Adalimumab in MTX Intolerant Patients with RA
E47: HCQ Blood Levels and HCQ Retinopathy
E46: Rituximab in Lupus
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Good Nurse Bad Nurse
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive